INTERNATIONAL PATENT: SHANGHAI VITALGEN BIOPHARMA CO., LTD. FILES APPLICATION FOR "METHODS FOR KALLIKREIN (KLKB1) GENE EDITING"

GENEVA, Jan. 12 -- SHANGHAI VITALGEN BIOPHARMA CO., LTD. (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210) filed a patent application (PCT/CN2025/107350) for "METHODS FOR KALLIKREIN (KLKB1) GENE EDITING" on Jul 07, 2025. With publication no. WO/2026/008078, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUO, Lu (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210), ZHANG, Hongwei (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210), ZHU, Xi (Building 2, No.11 Jialilue RoadPudong N...